Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

Development of biocompatible silicone hyrogels with high resistance to protein adsorption and bacterial adhesion.

Thermosensitive N-isopropylacrylamide–N–propylacrylamide-vinyl Pyrrolidone Terpolymers: Synthesis, Characterization and Preliminary Application As Embolic Agents

A Thermoresponsive Supramolecular Copolymer Hydrogel for the Embolization of Kidney Arteries.

Preparation and Evaluation of Biocompatible Long-Term Radiopaque Microspheres Based on Polyvinyl Alcohol and Lipiodol for Embolization

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Construction of an Injectable Composite Double-Network Hydrogel As a Liquid Embolic Agent.

In Situ Forming Supramolecular Nanofiber Hydrogel as a Biodegradable Liquid Embolic Agent for Postembolization Tissue Remodeling

Novel temperature responsive polymer based sealant for embolization

Development of robust biocompatible silicone with high resistance to protein adsorption and bacterial adhesion.

Hydrogels in endovascular embolization. IV. Effect of radiopaque spherical particles on the living tissue

Research of novel biocompatible radiopaque microcapsules for arterial embolization

Temperature-sensitive poly(N-isopropylacrylamide-co-butyl methylacrylate) nanogel as an embolic agent: distribution, durability of vascular occlusion, and inflammatory reactions in the renal artery of rabbits

Iodinated Cyanoacrylate‐based Novel Liquid Embolic Compositions with Inherent Radiopacity for Endovascular Embolization

Non-invasive monitoring of in vivo degradation of a radiopaque thermoreversible hydrogel and its efficacy in preventing post-operative adhesions

Fusible and Radiopaque Microspheres for Embolization

Precision Embolism: Biocompatible Temperature‐Sensitive Hydrogels as Novel Embolic Materials for Both Mainstream and Peripheral Vessels

Preparation and evaluation of ion-exchange porous polyvinyl alcohol microspheres as a potential drug delivery embolization system

Thrombin Immobilized Hemocompatible Radiopaque Polyurethane Microspheres for Topical Blood Coagulation

Radiopaque Highly Stiff and Tough Shape Memory Hydrogel Microcoils for Permanent Embolization of Arteries

Dynamic Agent of an Injectable and Self-Healing Drug-Loaded Hydrogel for Embolization Therapy.

Development of X-ray Opaque Poly(lactic Acid) End-Capped by Triiodobenzoic Acid Towards Non-Invasive Micro-Ct Imaging Biodegradable Embolic Microspheres